Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical firm dedicated to creating a novel class of small molecule antibiotics for challenging bacterial infections, announced that it has obtained positive regulatory guidance from the EMA in...
India's pharmaceutical industry plans to increase its size to over USD 120-130 billion by 2030, leveraging innovation to establish itself as the global healthcare guardian, according to Samir Mehta, president of the Indian Pharmaceutical Alliance...
Zydus Lifesciences Ltd announced that it has formed a partnership with CVS Caremark to include Zituvio, Zituvimet, and Zituvimet XR tablets, which are utilized for diabetes treatment, in the latter's standard formulary. Zydus Lifesciences Ltd...
Researchers at the Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (UPenn) created a novel screening method, Aptamer-based T Lymphocyte Activity Screening and SEQuencing (ATLAS-seq)...
India's pharmaceutical industry is expected to show strong earnings growth of 19.4% year-over-year for the October-December quarter (Q3 FY25), fueled by solid domestic formulation (DF) sales, specialized US generic launches, and lower raw material...
Astellas Pharma Inc. announced that China’s National Medical Products Administration (NMPA) has given the approval to Vyloy (zolbetuximab), in conjunction with fluoropyrimidine- and platinum-based chemotherapy, for the initial treatment of...
Pharmaceutical company Cipla announced the rollout of a mobile app aimed at facilitating the initial screening for asthma in India. The Global Burden of Disease report estimates that asthma's total burden in India is roughly 34.3 million...
German multinational pharmaceutical and biotechnology firm Bayer aims to bolster its presence in India by broadening its range of therapies and increasing collaborations throughout the healthcare ecosystem. Bayer has launched various treatments to...
NMD Pharma A/S, a biotech firm in the clinical stage focused on creating innovative and enhanced therapies for individuals with neuromuscular disorders, revealed that the U.S. Food and Drug Administration (FDA) has awarded orphan drug designation...
Hanx Biopharma, Inc. Ltd, a pioneering biotechnology firm focused on creating next-generation immunotherapies to tackle the challenges posed by unmet medical needs, announced the first patient dosing in Australia on December 30, 2024, for the...
, CDSCO.jpg)
